In brief: The RSV chapter now reflects MHRA approval of clesrovimab and JCVI advice on adult risk groups.
🔒 For Birmingham LMC member practices
The full text of this ICB brief item is available to GPs and staff in Birmingham practices. Log in to read it, or get access with your nhs.net email.